If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



House renews EPA inquiry

by Jessica Morrison
February 13, 2017 | A version of this story appeared in Volume 95, Issue 7

U.S. lawmakers are once again criticizing EPA for using science that is not publicly available in regulatory decision-making. At a hearing of the House of Representatives Science, Space & Technology Committee last week, chair Lamar Smith (R-Texas) warned that congressional efforts to curb EPA’s regulatory authority could be more successful with the new administration. In recent years, Smith and other committee members have sponsored “secret science” legislation that environmental advocates say would have stymied EPA’s pollution regulations. The legislation would have required EPA to base its regulatory actions on publicly available scientific data. Critics say the action would inhibit the use of peer-reviewed medical studies that commonly protect confidential patient information. Some people have questioned whether such legislation is an attack on the scientific process. “Scientists—whether in industry, academia, or the government—must have confidence that they can conduct their work in an atmosphere free of intimidation or undue influence,” Rush D. Holt Jr., CEO of the American Association for the Advancement of Science and former Democratic congressman, said at the hearing.

AAAS CEO Rush Holt and others testify during House committee hearing.
Credit: Carla Schaffer/AAAS
AAAS CEO Rush Holt (second from right) spoke against lawmaker-led reforms to the scientific process at a Feb. 7 congressional hearing.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.